Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | RECURSION PHARMACEUTICALS, INC. | Mauro David J
(Chief Medical Officer) |
F | Class A Common Stock | D | 4187 | $6.17 - $6.17 | $25,854 |
| 2024-11-15 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
F | Class A Common Stock | D | 11937 | $6.17 - $6.17 | $73,710 |
| 2024-11-15 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
F | Class A Common Stock | D | 14286 | $6.17 - $6.17 | $88,216 |
| 2024-11-15 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
F | Class A Common Stock | D | 26023 | $6.17 - $6.17 | $160,692 |
| 2024-11-13 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 40000 | $7.35 - $7.74 | $301,800 |
| 2024-11-13 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2024-11-12 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $7.64 - $7.64 | $87,457 |
| 2024-11-12 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 30000 | $7.64 - $7.66 | $229,504 |
| 2024-11-12 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 78750 | $2.22 - $2.22 | $174,824 |
| 2024-10-29 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $6.72 - $6.72 | $76,926 |
| 2024-10-24 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 6000 | $6.31 - $6.31 | $37,854 |
| 2024-10-24 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 6000 | $1.06 - $1.06 | $6,360 |
| 2024-10-15 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $6.67 - $6.67 | $76,326 |
| 2024-10-08 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 30000 | $6.32 - $6.36 | $190,130 |
| 2024-10-08 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 78750 | $2.22 - $2.22 | $174,824 |
| 2024-10-01 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
A | Class A Common Stock | A | 2026 | $0.00 - $0.00 | $0 |
| 2024-10-01 | RECURSION PHARMACEUTICALS, INC. | Dar Zavain
(Director) |
A | Class A Common Stock | A | 2229 | $0.00 - $0.00 | $0 |
| 2024-10-02 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 40000 | $6.08 - $6.16 | $244,800 |
| 2024-10-02 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 40000 | $0.00 - $0.00 | $0 |
| 2024-10-01 | RECURSION PHARMACEUTICALS, INC. | Li Dean Y
(Director) |
A | Class A Common Stock | A | 1925 | $0.00 - $0.00 | $0 |
| 2024-10-01 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $6.22 - $6.22 | $71,149 |
| 2024-09-26 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 6000 | $7.00 - $7.00 | $42,004 |
| 2024-09-26 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 6000 | $1.06 - $1.06 | $6,360 |
| 2024-09-17 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $6.84 - $6.84 | $78,332 |
| 2024-09-10 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 30000 | $6.17 - $6.32 | $187,228 |
| 2024-09-10 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 78750 | $2.22 - $2.22 | $174,824 |
| 2024-08-30 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
M | Class A Common Stock | A | 5000 | $2.48 - $2.48 | $12,400 |
| 2024-08-29 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
M | Class A Common Stock | A | 5000 | $2.48 - $2.48 | $12,400 |
| 2024-08-23 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
M | Class A Common Stock | A | 5000 | $2.48 - $2.48 | $12,400 |
| 2024-08-20 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $7.12 - $7.12 | $81,532 |
| 2024-08-15 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
F | Class A Common Stock | D | 14319 | $6.69 - $6.69 | $95,794 |
| 2024-08-15 | RECURSION PHARMACEUTICALS, INC. | Mauro David J
(Chief Medical Officer) |
F | Class A Common Stock | D | 14146 | $6.69 - $6.69 | $94,636 |
| 2024-08-15 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
F | Class A Common Stock | D | 26082 | $6.69 - $6.69 | $174,488 |
| 2024-08-15 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
F | Class A Common Stock | D | 11962 | $6.69 - $6.69 | $80,025 |
| 2024-08-13 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 30000 | $6.35 - $6.35 | $190,433 |
| 2024-08-13 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 78750 | $2.22 - $2.22 | $174,824 |
| 2024-08-07 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 50000 | $6.50 - $7.10 | $343,000 |
| 2024-08-07 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
| 2024-08-06 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $6.82 - $6.82 | $78,083 |
| 2024-07-25 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 6000 | $8.13 - $8.13 | $48,809 |
| 2024-07-25 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 6000 | $1.06 - $1.06 | $6,360 |
| 2024-07-23 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $8.48 - $8.48 | $97,040 |
| 2024-07-10 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
S | Class A Common Stock | D | 100000 | $7.47 - $7.48 | $747,500 |
| 2024-07-10 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
G | Class A Common Stock | D | 25000 | $0.00 - $0.00 | $0 |
| 2024-07-10 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 100000 | $0.00 - $0.00 | $0 |
| 2024-06-05 | RECURSION PHARMACEUTICALS, INC. | Gibson Christopher
(Chief Executive Officer) |
C | Class A Common Stock | A | 100000 | $0.00 - $0.00 | $0 |
| 2024-07-09 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 30000 | $7.24 - $7.32 | $218,353 |
| 2024-07-09 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 78750 | $2.22 - $2.22 | $174,824 |
| 2024-07-09 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $7.32 - $7.32 | $83,734 |
| 2024-06-27 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 6000 | $7.21 - $7.21 | $43,290 |
| 2024-06-27 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 6000 | $1.06 - $1.06 | $6,360 |
| 2024-06-25 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $9.51 - $9.51 | $108,806 |
| 2024-06-13 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
S | Class A Common Stock | D | 30000 | $9.27 - $9.32 | $278,879 |
| 2024-06-13 | RECURSION PHARMACEUTICALS, INC. | Secora Michael
(Chief Financial Officer) |
M | Class A Common Stock | A | 78750 | $2.22 - $2.22 | $174,824 |
| 2024-06-11 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $8.45 - $8.45 | $96,762 |
| 2024-06-03 | RECURSION PHARMACEUTICALS, INC. | Burrell Terry-Ann
(Director) |
A | Class A Common Stock | A | 13097 | $0.00 - $0.00 | $0 |
| 2024-06-03 | RECURSION PHARMACEUTICALS, INC. | HERSHBERG ROBERT
(Director) |
A | Class A Common Stock | A | 13097 | $0.00 - $0.00 | $0 |
| 2024-06-03 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
A | Class A Common Stock | A | 13097 | $0.00 - $0.00 | $0 |
| 2024-06-03 | RECURSION PHARMACEUTICALS, INC. | Dar Zavain
(Director) |
A | Class A Common Stock | A | 13097 | $0.00 - $0.00 | $0 |
| 2024-06-03 | RECURSION PHARMACEUTICALS, INC. | Li Dean Y
(Director) |
A | Class A Common Stock | A | 13097 | $0.00 - $0.00 | $0 |
| 2024-05-30 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
S | Class A Common Stock | D | 3000 | $8.78 - $8.78 | $26,325 |
| 2024-05-30 | RECURSION PHARMACEUTICALS, INC. | Marriott Tina
(President and COO) |
M | Class A Common Stock | A | 3000 | $1.06 - $1.06 | $3,180 |
| 2024-05-28 | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake
(Director) |
S | Class A Common Stock | D | 11447 | $9.17 - $9.17 | $104,942 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |